Initiation of research by Allenby Capital (RNS Reach announcement)

Cambridge, UK - 11th March 2021

Cambridge, UK – 11 March 2021: Nuformix plc (LSE:NFX), a pharmaceutical development company and drug re-purposing specialist, is pleased to announce the initiation of research by Allenby Capital Limited, the Company’s broker.

Download News

Back to all News